Cargando...
Clinical role of obinutuzumab in the treatment of naive patients with chronic lymphocytic leukemia
The introduction of targeted therapy against CD20(+) with the monoclonal antibody rituximab has dramatically improved the survival of B-cell non-Hodgkin lymphoma including chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma. Unfortunately, CLL remains incurable with chemoimmunotherapy, wit...
Guardado en:
| Publicado en: | Biologics |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Dove Medical Press
2015
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4337412/ https://ncbi.nlm.nih.gov/pubmed/25733804 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BTT.S61600 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|